Biorsaf raises €5.2m to build Italy's Food RegTech platform

Milan-based Biorsaf has closed a €5.2 million funding round led by Italian venture capital firm P101, alongside the acquisition of food-information platform Cooki, to build what the company describes as Italy's first end-to-end Food RegTech platform. The deal brings together food-safety compliance (HACCP), traceability, nutritional labelling, allergen management and cost analysis under a single digital stack, targeting a domestic market of roughly 3.4 million businesses that collectively generate over €12 billion in revenue, yet where digital adoption stands at a striking 3%.

The combined entity positions Biorsaf at the intersection of regulatory technology, food supply-chain digitisation, and artificial intelligence, a convergence that is attracting growing investor attention well beyond Italy's borders. The company says it saved its active user base an estimated €30 million in operating costs in 2025, and its platform now serves more than 10,000 users, including large restaurant groups and retail operators such as Conad.

RegTech meets the food supply chain

Biorsaf's core product, BS-Safe, automates control processes that were historically paper-based, cutting an estimated 30 minutes of manual work per user per day. Cooki, founded in 2017 by Giuseppe Grammatico, adds a database of more than 35,000 coded food products and automates traceability, allergen risk and stock management across more than 450 Italian cities. Together, the platforms are intended to cover every compliance and data-management step along the food value chain, from farm inputs to consumer labelling.

Central to the three-year growth plan is an AI layer designed to automate quality, safety and operations management. Biorsaf says it has already built what it calls the first professional AI agent dedicated to digital food safety management, handling monitoring, compliance documentation and regulatory reporting for specialist consultants. CEO Marco Papalini framed the ambition in consolidation terms: "Our goal is to scale rapidly, both organically and through market consolidation and technological innovation, putting artificial intelligence to work for the efficiency of businesses in the food sector."

P101 partner Giuseppe Donvito pointed to Biorsaf's position in a heavily regulated vertical as the core investment thesis: "Biorsaf has everything we look for in a RegTech company: strong technology, deep vertical expertise and position in a highly regulated market."

Capital landscape and convergence read-across

The round drew in several co-investors with structural significance beyond the deal itself. Maia Ventures specialises in agrifoodtech; Farming Future is a national agrifoodtech technology transfer hub; and Toscana Next is a regional co-investment fund backed by four Tuscan banking foundations including Fondazione Monte dei Paschi di Siena, supported through CDP Venture Capital. The structure reflects a pattern visible across southern Europe: public development capital, regional banking foundations and specialist VC converging on digital infrastructure for regulated industries, using EU NextGenerationEU and InvestEU resources to de-risk early-stage bets.

For cross-sector strategists, the macro read-across is worth noting. Food RegTech is a microcosm of a broader regulatory digitisation wave sweeping industries where compliance costs are high, audit trails are mandated, and paper-based processes create liability exposure, food, pharma manufacturing, water utilities, and workplace safety all share this profile. P101's own portfolio data is instructive: RegTech now accounts for nearly 20% of investments made through its Programma 103 vehicle, following earlier bets on Aptus.AI and A-Cube. That concentration suggests the firm is building a deliberate thesis around AI-augmented compliance infrastructure across regulated Italian verticals, not simply making opportunistic food-sector bets.

The Biorsaf play also raises questions about M&A velocity in fragmented European vertical-SaaS markets. With a stated buy-and-build strategy, 3% digitisation penetration as headroom, and EU digital-transition funding providing a subsidised cost of capital, the company's consolidation ambitions could replicate a pattern seen in other compliance-heavy European niches: rapid platform aggregation ahead of a potential exit to a larger enterprise-software or supply-chain-tech acquirer. Whether Italy's food-safety market can sustain a standalone platform at scale, or whether Biorsaf becomes a regional bolt-on for a pan-European RegTech roll-up, is the strategic question investors will be watching over the three-year plan horizon.